Controversy IV: Population Pharmacokinetics, NONMEM and the Pharmacokinetic Screen; Academic, Industrial and Regulatory Perspectives
- 1 January 1989
- journal article
- Published by Wiley in The Journal of Clinical Pharmacology
- Vol. 29 (1) , 1-6
- https://doi.org/10.1002/j.1552-4604.1989.tb03230.x
Abstract
No abstract availableThis publication has 13 references indexed in Scilit:
- An evaluation of population pharmacokinetics in therapeutic trials. Part I. Comparison of methodologiesClinical Pharmacology & Therapeutics, 1986
- Premarketing observational studies of population pharmacokinetics of new drugsClinical Pharmacology & Therapeutics, 1985
- Population pharmacokinetics of racemic warfarin in adult patientsJournal of Pharmacokinetics and Biopharmaceutics, 1985
- 2. Experience with Nonmem: Analysis of Serum Concentration Data in Patients Treated with Mexiletine and LidocaineDrug Metabolism Reviews, 1984
- Population Pharmacokinetics of Procainamide from Routine Clinical DataClinical Pharmacokinetics, 1984
- Evaluation of methods for estimating population pharmacokinetic parameters. III. Monoexponential model: Routine clinical pharmacokinetic dataJournal of Pharmacokinetics and Biopharmaceutics, 1983
- Steady-state Pharmacokinetics of Phenytoin from Routinely Collected Patient Data???Clinical Pharmacokinetics, 1983
- Population pharmacokinetic parameters in patients treated with oral mexiletineEuropean Journal of Clinical Pharmacology, 1982
- The NONMEM SystemThe American Statistician, 1980
- Estimation of population characteristics of pharmacokinetic parameters from routine clinical dataJournal of Pharmacokinetics and Biopharmaceutics, 1977